El Salvador Sets Up New Regulatory Body To Oversee Medicines & Devices

 
• By Francesca Bruce
  
Generate a summary of this article
Listen to this article
Beta

El Salvador has approved a law that will establish a new regulatory body responsible for authorizing medicines and setting prices.

El Salvador
El Salvador Strengthens Regulatory environment for medicines • Source: Shutterstock

El Salvador is to create the Superintendency for Health Regulation (SHR), a new regulatory body that will authorize medicines and medical devices, grant export and import licenses and set medicine prices. The move is expected to strengthen the national health system and protect patients, as well as make El Salvador a more competitive pharmaceutical market.

Earlier this month, the country’s legislative assembly passed the Health Regulation Superintendency bill, which will establish the new entity. The...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Latin America

Brazil Issues Guidance On Regulatory Reliance & Equivalent Authorities

 
• By Francesca Bruce

Brazilian regulator Anvisa is relying on the decisions of its foreign counterparts as a means of ensuring more quality medicines are made available in the country.

Anvisa To Access US FDA-Reviewed Data For More Robust Evaluations In Brazil

 
• By Francesca Bruce

Brazil has also published its recent regulatory reliance regulations in English, a move designed to increase confidence in its decisions as it presses on with aligning its national practices with global best practices.

Colombia Signs Agreement With PAHO To Strengthen Regulatory Capacity

 
• By Francesca Bruce

The deal comes at a time when Latin American countries are increasingly looking to improve the regulatory environment for pharmaceuticals and move towards greater convergence.

Mexico Launches ‘Regulatory Certainty Strategy’ For Biosimilars

 
• By Francesca Bruce

Mexico is to establish a new regulatory framework that is in line with international standards to encourage domestic production of biosimilar medicines. 

More from Geography

Canada Cuts Red Tape With Single Ethics Review For Trials

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

Nancy Test Circulable Section Geography

 
• By Brian Bossetta

This is a short description

Diversity Action Plans: What To Submit And When

 
• By Nielsen Hobbs

With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.